ArticleHepatology international2021
Sorafenib for advanced hepatocellular carcinoma provides better prognosis after liver transplantation than without liver transplantation.
Soon Kyu Lee et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it